MMMikkel Madsen

Mikkel Madsen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mikkel Madsen has a total of 63 co-authors. Here are the top co-authors by number of shared publications:

  • Birte Svensson

    Enzyme and Protein Chemistry, Department of Biotechnology and Biomedicine Technical University of Denmark Kgs. Lyngby Denmark

    10 shared publications
  • Finn Lillelund Aachmann

    Department of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology, Trondheim, Norway

    7 shared publications
  • Mette E. Rønne

    Department of Autoimmunology and Biomarkers, Statens Serum Institut, Copenhagen, Denmark

    5 shared publications
  • Casper Wilkens

    Structural Enzymology, Department of Biotechnology and Biomedicine, Technical University of Denmark, Søltofts Plads 221, DK-2800 Kongens Lyngby, Denmark; Present address: Tate & Lyle, Lille Skensved, Denmark

    4 shared publications
  • Tobias Tandrup

    Department of Biotechnology and Biomedicine The Technical University of Denmark Søltofts Plads Building 221 DK‐2800 Kgs. Lyngby Denmark

    4 shared publications
  • Leesa Jane Klau

    Norwegian Biopolymer Laboratory (NOBIPOL), Department of Biotechnology and Food Science, NTNU Norwegian University of Science and Technology, Sem Sælands Vei 6/8, N-7491, Trondheim, Norway; Present address: Department of Process Technology, SINTEF Industry, Oslo, Norway

    3 shared publications

Latest Publications

  • Open Access

    Dissecting a two-domain alginate lyase of family PL6 reveals a mechanistic basis for substrate specificity and enzyme activity

    by Mikkel Madsen, Mette E. Rønne, Agnes B. Petersen, Tobias Tandrup, Bo Pilgaard, Jesper Holck, Finn L. Aachmann, Casper Wilkens, Leesa J. Klau, Birte Svensson


  • The Swiss Army Knife of Alginate Metabolism: Mechanistic Analysis of a Mixed-Function Polysaccharide Lyase/Epimerase of the Human Gut Microbiota

    by Tobias Tandrup, José Pablo Rivas-Fernández, Mikkel Madsen, Mette E. Rønne, Agnes B. Petersen, Leesa J. Klau, Anne Tøndervik, Casper Wilkens, Finn L. Aachmann, Carme Rovira, et al.

    The alginate-degrading enzyme BoPL38 of the human gut bacterium Bacteroides ovatus CP926 degrades all three polysaccharide structures found in alginate, a major constituent of brown macroalgae, making it a valuable tool for the selective production of alginate oligosaccharides with industrial and biotechnological potential. Despite its abundance, alginate's heterogeneous composition limits its full utilization. Modification by epimerases and lyases can help to overcome this limitation, but typically requires distinct enzymes for each polysaccharide structure. Here, we combined experimental and computational approaches to elucidate the catalytic machinery that enables BoPL38 to act across all alginate structures. We resolved in crystallo complexes of BoPL38 with alginate oligosaccharides, providing key insights into substrate binding. These structures informed QM/MM MD simulations, which uncovered distinct conformational and reaction pathways for mannuronate and guluronate conversion. The simulations identified different transition states, showing how a single active site architecture facilitates C5 proton abstraction at subsite +1 by Y298 and H243, enabling syn- and anti-β-elimination, respectively. A well-defined residue network mediates substrate recognition, and site-directed mutagenesis revealed that disruption of this network destabilizes the active site architecture. Notably, R292 plays a critical role in distorting the sugar at subsite +1 into a preactivated conformation while also stabilizing the active site tunnel through a salt bridge. Finally, NMR spectroscopy revealed that BoPL38 also catalyzes mannuronate-to-guluronate epimerization, highlighting its multifunctionality. These findings provide molecular insight into how a single enzyme accommodates alginate's structural diversity and offer new opportunities for enzymatic polysaccharide engineering.


  • Open Access

    The Swiss Army Knife of Alginate Manipulation – A Gut Bacterium Alginate Lyase with Diverse Catalytic Activities

    by Tobias Tandrup, José Pablo Rivas-Fernández, Mikkel Madsen, Mette E. Rønne, Agnes B. Petersen, Leesa J. Klau, Anne Tøndervik, Casper Wilkens, Finn L. Aachmann, Carme Rovira, et al.

    The alginate-degrading enzyme Bo PL38 of the human gut bacterium Bacteroides ovatus CP926 degrades the three polysaccharide structures found in alginate, a major constituent of brown macroalgae with numerous industrial applications. However, the detailed mechanisms of alginate-degrading enzymes remain unclear. Crystal structures of Bo PL38 complexes with alginate oligosaccharides, now shed light on the enzyme’s catalytic machinery. QM/MM simulations reveal distinct conformational and reaction pathways, highlighting different transition states for mannuronate and guluronate conversion. C5 proton abstraction at subsite +1 by Y298 and H243 facilitates syn- and anti -β-elimination reactions, respectively. Substrate recognition relies on R292 distorting the sugar at subsite +1 into a preactivated conformation, while stabilizing the active site tunnel through a salt bridge. Furthermore, NMR spectroscopy found that Bo PL38 also catalyze mannuronate to guluronate epimerization in addition to its lyase function, thereby paving the way for future enzymatic alginate modification.

  • Three alginate lyases provide a new gut Bacteroides ovatus isolate with the ability to grow on alginate

    by Mette E. Rønne, Tobias Tandrup, Mikkel Madsen, Cameron J. Hunt, Pernille N. Myers, Janne M. Moll, Jesper Holck, Susanne Brix, Mikael L. Strube, Finn L. Aachmann, et al.

    Humans consume alginate in the form of seaweed, food hydrocolloids, and encapsulations, making the digestion of this mannuronic acid (M) and guluronic acid (G) polymer of key interest for human health. To increase knowledge on alginate degradation in the gut, a gene catalog from human feces was mined for potential alginate lyases (ALs). The predicted ALs were present in nine species of the Bacteroidetes phylum, of which two required supplementation of an endo -acting AL, expected to mimic cross-feeding in the gut. However, only a new isolate grew on alginate. Whole-genome sequencing of this alginate-utilizing isolate suggested that it is a new Bacteroides ovatus strain harboring a polysaccharide utilization locus (PUL) containing three ALs of families: PL6, PL17, and PL38. The Bo PL6 degraded polyG to oligosaccharides of DP 1–3, and Bo PL17 released 4,5-unsaturated monouronate from polyM. Bo PL38 degraded both alginates, polyM, polyG, and polyMG, in endo -mode; hence, it was assumed to deliver oligosaccharide substrates for Bo PL6 and Bo PL17, corresponding well with synergistic action on alginate. Bo PL17 and Bo PL38 crystal structures, determined at 1.61 and 2.11 Å, respectively, showed (α/α) 6 -barrel + anti-parallel β-sheet and (α/α) 7 -barrel folds, distinctive for these PL families. Bo PL17 had a more open active site than the two homologous structures. Bo PL38 was very similar to the structure of an uncharacterized PL38, albeit with a different triad of residues possibly interacting with substrate in the presumed active site tunnel. Altogether, the study provides unique functional and structural insights into alginate-degrading lyases of a PUL in a human gut bacterium. IMPORTANCE: Human ingestion of sustainable biopolymers calls for insight into their utilization in our gut. Seaweed is one such resource with alginate, a major cell wall component, used as a food hydrocolloid and for encapsulation of pharmaceuticals and probiotics. Knowledge is sparse on the molecular basis for alginate utilization in the gut. We identified a new Bacteroides ovatus strain from human feces that grew on alginate and encoded three alginate lyases in a gene cluster. Bo PL6 and Bo PL17 show complementary specificity toward guluronate (G) and mannuronate (M) residues, releasing unsaturated oligosaccharides and monouronic acids. Bo PL38 produces oligosaccharides degraded by Bo PL6 and Bo PL17 from both alginates, G-, M-, and MG-substrates. Enzymatic and structural characterization discloses the mode of action and synergistic degradation of alginate by these alginate lyases. Other bacteria were cross-feeding on alginate oligosaccharides produced by an endo-acting alginate lyase. Hence, there is an interdependent community in our guts that can utilize alginate.


  • Tuning alginate β-lactoglobulin complex coacervation by modulating pH and temperature

    by Mikkel Madsen, Hossein Mohammad-Beigi, Peter Westh, Finn L. Aachmann, Birte Svensson

    The use of biomolecules in food matrices and encapsulation systems is, as in other areas, moving towards greener solutions and a center piece here is the complex coacervation between natural anionic polysaccharides and proteins. Both alginate and β-lactoglobulin (β-Lg) are used in different sectors and have been shown to coacervate at pH < 5.2. Albeit with increased interest, complex coacervation has almost exclusively been studied from a macromolecular perspective, and described as an interaction based on charge–charge attraction. Here, we show that through changes in pH and temperature, alginate β-Lg complex coacervation can be tuned to purpose. By detailed biophysical and chemical characterization of coacervation and coacervate particles, insights into the molecular interaction and effect of external factors are obtained. We find that carboxylate resonance stabilization causes a release of protons at pH < pKa,alginate and an uptake of protons at pH > pKa,alginate upon coacervation. Proton release and uptake were quantified at pH 2.65 and 4.00 by isothermal titration calorimetry to be 4 and 2 protons per β-Lg molecule, respectively. By increasing the temperature to 65 °C, we discovered a secondary β-Lg concentration dependent coacervation step, where the formed particles change into large assemblies driven by entropy. These findings bring new insights to complex coacervation and its applicability in microencapsulation and drug delivery.


  • Open Access

    Molecular insights into alginate β‐lactoglobulin A multivalencies—The foundation for their amorphous aggregates and coacervation

    by Mikkel Madsen, Andreas Prestel, Eva Madland, Peter Westh, Anne Tøndervik, Håvard Sletta, Günther H. J. Peters, Finn L. Aachmann, Birthe B. Kragelund, Birte Svensson

    For improved control of biomaterial property design, a better understanding of complex coacervation involving anionic polysaccharides and proteins is needed. Here, we address the initial steps in condensate formation of β‐lactoglobulin A (β‐LgA) with nine defined alginate oligosaccharides (AOSs) and describe their multivalent interactions in structural detail. Binding of AOSs containing four, five, or six uronic acid residues (UARs), either all mannuronate (M), all guluronate (G), or alternating M and G embodying the block structural components of alginates, was characterized by isothermal titration calorimetry, nuclear magnetic resonance spectroscopy (NMR), and molecular docking. β‐LgA was highly multivalent exhibiting binding stoichiometries decreasing from five to two AOSs with increasing degree of polymerization (DP) and similar affinities in the mid micromolar range. The different AOS binding sites on β‐LgA were identified by NMR chemical shift perturbation analyses and showed diverse compositions of charged, polar and hydrophobic residues. Distinct sites for the shorter AOSs merged to accommodate longer AOSs. The AOSs bound dynamically to β‐LgA, as concluded from saturation transfer difference and 1H‐ligand‐targeted NMR analyses. Molecular docking using Glide within the Schrödinger suite 2016‐1 revealed the orientation of AOSs to only vary slightly at the preferred β‐LgA binding site resulting in similar XP glide scores. The multivalency coupled with highly dynamic AOS binding with lack of confined conformations in the β‐LgA complexes may help explain the first steps toward disordered β‐LgA alginate coacervate structures.


  • Open Access

    Association of caseins with β-lactoglobulin influenced by temperature and calcium ions: A multi-parameter analysis

    by Hossein Mohammad-Beigi, Wahyu Wijaya, Mikkel Madsen, Yuya Hayashi, Ruifen Li, Tijs Albert Maria Rovers, Tanja Christine Jæger, Alexander K. Buell, Anni Bygvrå Hougaard, Jacob J.K. Kirkensgaard, et al.


  • Simulated gastrointestinal digestion of protein alginate complexes: effects of whey protein cross-linking and the composition and degradation of alginate

    by Mikkel Madsen, Mette E. Rønne, Ruifen Li, Ines Greco, Richard Ipsen, Birte Svensson

    Alginate and whey protein are common additives in food production improving storage stability, texture and nutritional value. Alginate forms complexes with whey protein and inhibits proteolysis by pepsin and trypsin, but the influence of alginate protein complexation on digestion is poorly understood. This study shows that whey protein cross-linking by microbial transglutaminase dramatically decreased particle size (2-fold) and viscosity of alginate protein complexes. The INFOGEST in vitro simulated gastrointestinal digestion of whey protein was increased by cross-linking (16%) and suppressed by alginate, most pronounced with high mannuronic acid and least with high guluronic acid content. Sizes of alginate whey protein particles increased during gastric digestion, whereas for cross-linked whey protein complexes the size initially increased, but returned to their initial size at the end of gastric digestion. While alginate is not degraded by human enzymes, a few gut bacteria were recently found to encode lyases and other enzymes metabolizing alginate. Alginate lyase added to the intestinal phase enhanced digestion (9%) as controlled by alginate composition and enzyme specificity. Thus we provide evidence that use of hydrocolloids and processing of protein strongly influence digestion and should be considered when using food additives.


  • Open Access

    Transglutaminase Cross-Linking of Whey Proteins Affects Alginate Complexation

    by Mikkel Madsen, Sanaullah Khan, Sonja Kunstmann, Finn Aachmann, Richard Ipsen, Peter Westh, Cecilia Emanuelsson, Birte Svensson

    Cross-linked proteins can serve as ingredients generating new food matrix interactions. Generally, cross-linking of whey proteins requires harsh conditions, but here microbial transglutaminase (MTG) cross-linked whey proteins and the major constituent β-lactoglobulin (β-Lg) effectively under mild alkaline conditions without prior heating or reducing agent addition. Cross-linked β-Lg spanned 18 to >240 kDa and mass spectrometry identified 6 of 9 glutamines reacting with 8 of 15 lysines. The initial isopeptide bond formation caused loss of β-Lg native structure with t 1/2 = 3 h, while the polymerization occurred with t 1/2 = 10 h, as shown by fluorescence, circular dichroism and size exclusion chromatography analyses. Complexation with alginate was monitored by dynamic light scattering, turbidimetry and isothermal titration calorimetry and indicated that β-Lg cross-linking decreased onset of particle formation, hydrodynamic diameter, stoichiometry (β-Lg/alginate) and dissociation constant. Temperature dependent enthalpy and entropy changes suggested hydrophobic interactions were important for alginate-cross-linked β-Lg complexation.

  • Open Access

    Binding Sites for Oligosaccharide Repeats from Lactic Acid Bacteria Exopolysaccharides on Bovine β-Lactoglobulin Identified by NMR Spectroscopy

    by Johnny Birch, Sanaullah Khan, Mikkel Madsen, Christian Kjeldsen, Marie Sofie Møller, Emil G. P. Stender, Günther H. J. Peters, Jens Ø. Duus, Birthe B. Kragelund, Birte Svensson